checkAd
    Startseite > Aktien > ORIC Pharmaceuticals > Nachrichten
    ORIC Pharmaceuticals Aktie
    8,1000
     
    EUR
    -1,22 %
    -0,1000 EUR
    Letzter Kurs 09:31:17 Tradegate
    8,0000
     
    EUR
    630 STK
    Geldkurs 19:18:15
    8,0500
     
    EUR
    620 STK
    Briefkurs 19:18:15
    ISIN: US68622P1093 · WKN: A2P208 · SYM: 4TZ · USA

    Neueste Nachrichten

    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    07.06.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    29.05.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
    06.05.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
    15.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    08.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    04.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
    11.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
    06.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    05.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · ORIC Pharmaceuticals